Opinions expressed by Forbes Contributors are their own. Joshua Cohen is a Boston-based writer who covers health policy. Yesterday, Amgen announced that it would launch the U.S.’s first marketed ...

Adding the PCSK9 inhibitor led to greater absolute reductions in CVD risk than in younger patients, with no signs of safety ...

A dozen wake Technical Community College students signed letters of intent on Monday to work with Amgen. Amgen is planning a $1 billion expansion in Holly Springs. “This is a really good ...

ADP Jobs Data; Earnings Movers. Early Wednesday, ADP's January employment report showed jobs growth of 183,000, above the 153,000 Econoday estimate and up from December's increase ...

“Simply because Amgen discovered the purified gene does not give them the right to the gene in its natural environment,” says Mark Hofer, an attorney at Brown, Rudnick, Freed & Gesmer (Boston ...

The latest trading session saw Amgen (AMGN) ending at $267.10, denoting a -1.14% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 0.12% for the ...

In order to focus its resources on its lead antibody-drug conjugate (ADC) and an array of Big Pharma partnerships, CytomX is considering the future of the Amgen-partnered CX-904, the company said ...

Amgen's stock price remains nearly unchanged over 1.5 years, but its valuation may now be more reasonable or even a bargain. Despite high debt from the Horizon Therapeutics acquisition, Amgen ...